Prime Therapeutics, St. Paul, MN-Do quantity limits on abortive migraine medications (ie, triptans) and educational efforts to increase the use of prophylactic therapy reduce total health care costs over the long term?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Acute migraine therapy: Triptan quantity limit maintains total health care savings 1 year out

Newsletter